• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    China Everbright (SEHK:165) Appeal Advances, Is The Stock Fully Priced?

    Simply Wall St·10/25/2026 02:32:18
    Listen to the news

    China Everbright (SEHK:165) is back in focus after the High People’s Court of Chongqing Municipality accepted its appeal in an equity transfer dispute involving about RMB 1.878b, which keeps the earlier judgment from taking legal effect.

    At a share price of HK$5.195, China Everbright has seen short term pressure, with the 7 day share price return down 8.62% and the 30 day share price return down 17.41%. The 1 year total shareholder return declined 51.60%, even as the 3 year total shareholder return remains positive at 16.27%. This suggests that momentum has been fading, and this legal uncertainty is now feeding into how investors are assessing risk around the stock.

    Stress test your exposure to China Everbright style legal and balance sheet risk by scanning our hand picked 222 resilient stocks with low risk scores that aim for resilience when headlines turn messy.

    China Everbright still controls sizeable fund and principal investment platforms, yet the share price has been hit hard in recent months. Is this a solid franchise that has been temporarily marked down, or a fair price that reflects rising legal and earnings risk?

    Preferred Price-to-Sales Multiple of 10.6x: Is it justified?

    Valuation looks tight here. At a last close of HK$5.195, China Everbright trades on a P/S ratio of 10.6x, which is rich compared to both its peers and an estimate of where that multiple could settle over time.

    P/S compares the company’s market value with its annual revenue, so it tells you how much investors are willing to pay for each dollar of sales. For a capital markets group like China Everbright, a high P/S can signal that shareholders are banking on strong future fee income or profitable exits from its fund and principal investment platforms.

    The challenge is that China Everbright is currently loss making, with reported net losses of HK$4,467.09m and a negative return on equity of 12.72%. In that context, paying 10.6x sales looks aggressive when set against the estimated fair P/S of 0.9x, which is far lower and suggests a level the market could move towards if expectations cool. The P/S of 10.6x is also much higher than both the Hong Kong capital markets industry average of 3.2x and the peer group average of 4.2x. This points to a valuation that is materially more expensive than comparable businesses.

    Explore the SWS fair ratio for China Everbright.

    Result: Price-to-Sales of 10.6x (OVERVALUED)

    Still, the legal appeal in Chongqing and the recent net loss of HK$4,467.09m both remain clear swing factors that could challenge the upbeat China Everbright narrative.

    Find out about the key risks to this China Everbright narrative.

    Next Steps

    Sentiment around China Everbright is clearly split, which is exactly when fresh data matters most, so move quickly and weigh both sides by checking the 1 key reward and 1 important warning sign.

    Looking for more investment ideas beyond China Everbright?

    If China Everbright feels too finely balanced for your taste, consider broadening your watchlist and reviewing your portfolio with a few targeted stock searches.